Table 3 Hazard ratios and 95% confidence intervals for incident metabolic syndrome by GGT quartiles in men and women
GGT quartiles in men | GGT quartiles in women | |||||||
|---|---|---|---|---|---|---|---|---|
Q1 (≤ 17) | Q2 (18–27) | Q3 (28–47) | Q4 (≥ 48) | Q1 (≤ 9) | Q2 (10–12) | Q3 (13–16) | Q4(≥ 17) | |
Total, n | 803 | 762 | 797 | 765 | 752 | 775 | 622 | 681 |
New cases of type 2 diabetes, n | 208 | 270 | 334 | 403 | 279 | 319 | 280 | 385 |
Mean follow-up (years) | 8.7 (3.6) | 8.5 (3.6) | 7.7 (3.6) | 6.9 (3.6) | 8.3 (3.9) | 7.8 (4.0) | 7.6 (4.1) | 6.6 (4.0) |
Person-years of follow-up | 6989 | 6513 | 6143 | 5298 | 6265 | 6054 | 4758 | 4488 |
Incidence rate per 1000 person-year | 29.8 | 41.5 | 54.4 | 76.1 | 44.5 | 52.7 | 58.8 | 85.8 |
Model 1 | 1.00 (ref) | 1.22 (0.94–1.58) | 2.01 (1.59–2.54) | 3.05 (2.33–3.73) | 1.00 (ref) | 1.15 (0.81–1.63) | 1.17 (0.83–1.65) | 1.76 (1.27–2.43) |
Model 2 | 1.00 (ref) | 1.21 (0.94–1.58) | 2.00 (1.58–2.54) | 3.04 (2.32–3.71) | 1.00 (ref) | 1.13 (0.79–1.60) | 1.17 (0.83–1.64) | 1.72 (1.24–2.39) |
Model 3 | 1.00 (ref) | 1.21 (0.94–1.58) | 2.03 (1.60–2.58) | 3.01 (2.35–3.76) | 1.00 (ref) | 1.10 (0.77–1.58) | 1.11 (0.78–1.57) | 1.83 (1.30–2.57) |